SCHEMBL1860427

SCHEMBL1860427

C=CC(=O)NCc1ccccc1OC(C)(C)C

nearest known ligand 0.60

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HPGD P15428 4/20 0.43
KMT2A Q03164 6/20 0.43
ALDH1A1 P00352 5/20 0.42
MEN1 O00255 3/20 0.42
POLB P06746 1/20 0.42
MAPT P10636 1/20 0.42
BLM P54132 1/20 0.42
HTT P42858 2/20 0.42
NPSR1 Q6W5P4 1/20 0.42
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
CYP3A4 P08684 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
TGM2 P21980 1/20 0.41
HDAC1 Q13547 1/20 0.41
GAA P10253 2/20 0.40
KDM4E B2RXH2 1/20 0.40
RCE1 Q9Y256 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1866948 0.84 HPGD (0.40) HPGDKMT2AALDH1A1MEN1POLB
SCHEMBL8765637 0.84 HPGD (0.61) HPGDKMT2AALDH1A1MEN1POLB
SCHEMBL8479171 0.81 LMNA (0.54) HPGDKMT2AALDH1A1MEN1POLB
SCHEMBL59858 0.79 TGM2 (0.55) HPGDKMT2AALDH1A1NPC1RAB9A
SCHEMBL1865026 0.79 NPSR1 (0.47) HPGDKMT2AALDH1A1MEN1POLB
SCHEMBL1858964 0.77 HPGD (0.46) HPGDKMT2AALDH1A1MEN1POLB
SCHEMBL32665553 0.76 ELANE (0.41) HPGDKMT2AALDH1A1MEN1POLB
SCHEMBL15338437 0.75 HDAC3 (0.50) CYP3A4CYP2C9CYP2C19HDAC1
SCHEMBL8765327 0.75 NPC1 (0.66) KMT2AALDH1A1MEN1POLBHTT
SCHEMBL5082541 0.75 KMT2A (0.67) HPGDKMT2AALDH1A1MEN1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7939241-B2 (Meth)acrylamide derivative, polymer, chemically amplified photosensitive resin composition, and patterning method NEC CORPORATION (JP) 2011-05-10 US disclosed
US-20090068587-A1 (Meth) acrylamide derivative, polymer, chemically amplified photosensitive resin composition, and patterning method NEC CORPORATION (JP) 2009-03-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090068587-A1 (Meth) acrylamide derivative, polymer, chemically amplified photosensitive resin composition, and patterning method MMAB, DNMT3A, MAT1A HPGD 1849/4885KMT2A 185/4885ALDH1A1 184/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.